AAAAAA

   
Results: 1-10 |
Results: 10
High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity
Authors: Deporte-Fety, R Picot, M Amiand, M Moreau, A Campion, L Lanoe, D Renee, N Milano, G
Citation: R. Deporte-fety et al., High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity, J CHROMAT B, 762(2), 2001, pp. 203-209
Long-term complications of total body irradiation in adults
Authors: Thomas, O Mahe, MA Campion, L Bourdin, S Milpied, N Brunet, G Lisbona, A Le Mevel, A Moreau, P Harousseau, JL Cuilliere, JC
Citation: O. Thomas et al., Long-term complications of total body irradiation in adults, INT J RAD O, 49(1), 2001, pp. 125-131
Genetic polymorphism at the glutathione S-tranferase (GST) P1 locus is a breast cancer risk modifier
Authors: Maugard, CM Charrier, J Pitard, A Campion, L Akande, O Pleasants, L Ali-Osman, F
Citation: Cm. Maugard et al., Genetic polymorphism at the glutathione S-tranferase (GST) P1 locus is a breast cancer risk modifier, INT J CANC, 91(3), 2001, pp. 334-339
Hypertrophic cardiomyopathy: Long-term clinical outcome in a regional cohort of 243 patients
Authors: Gueffet, JP Langlard, JM Burban, M Campion, L Bouhour, JB
Citation: Jp. Gueffet et al., Hypertrophic cardiomyopathy: Long-term clinical outcome in a regional cohort of 243 patients, ARCH MAL C, 94(9), 2001, pp. 967-974
Salvage extended-field irradiation in follicular nonHodgkin's lymphoma after failure of chemotherapy
Authors: Mahe, MA Bourdin, S Mevel, AL Moreau, P Campion, L Hamidou, M Milpied, N Moreau, A Gaillard, F Harousseau, JL Cuilliere, JC
Citation: Ma. Mahe et al., Salvage extended-field irradiation in follicular nonHodgkin's lymphoma after failure of chemotherapy, INT J RAD O, 47(3), 2000, pp. 735-738
Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement
Authors: Kraeber-Bodere, F Campion, L Rousseau, C Bourdin, S Chatal, JF Resche, I
Citation: F. Kraeber-bodere et al., Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement, EUR J NUCL, 27(10), 2000, pp. 1487-1493
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections
Authors: Kraeber-Bodere, F Faivre-Chauvet, A Sai-Maurel, C Campion, L Fiche, M Gautherot, E Le Boterff, J Barbet, J Chatal, JF Thedrez, P
Citation: F. Kraeber-bodere et al., Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: Comparison of iodine 131-labeled F(ab ')(2) and pretargeted bivalent hapten and evaluation of repeated injections, CLIN CANC R, 5(10), 1999, pp. 3183S-3189S
Antithyroid drugs and Graves' disease - prospective randomized assessment of long-term treatment
Authors: Maugendre, D Gatel, A Campion, L Massart, C Guilhem, I Lorcy, Y Lescouarch, J Herry, JY Allannic, H
Citation: D. Maugendre et al., Antithyroid drugs and Graves' disease - prospective randomized assessment of long-term treatment, CLIN ENDOCR, 50(1), 1999, pp. 127-132
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft
Authors: Kraeber-Bodere, F Faivre-Chauvet, A Sai-Maurel, C Gautherot, E Fiche, M Campion, L Le Boterff, J Barbet, J Chatal, JF Thedrez, P
Citation: F. Kraeber-bodere et al., Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft, J NUCL MED, 40(1), 1999, pp. 198-204
C282Y hemochromatosis mutation does not contribute to hypercoagulability in a factor V Leiden population referred for venous thrombosis
Authors: Lellouche, F Dorval, I Corvisier, JM Jezequel, P Campion, L
Citation: F. Lellouche et al., C282Y hemochromatosis mutation does not contribute to hypercoagulability in a factor V Leiden population referred for venous thrombosis, BLOOD, 93(6), 1999, pp. 2135-2136
Risultati: 1-10 |